Viral Clearance Studies
|
|
- Martina Fisher
- 5 years ago
- Views:
Transcription
1 Viral Clearance Studies
2 viral clearance studies from the industry leader with unmatched experience and expertise Viral clearance is a critical component of regulatory submissions as it helps demonstrate overall safety of products. Laboratory scale-down models validate your downstream purification process for removal/inactivation of adventitious agents. The design of an effective viral clearance platform is essential for continual success. 25+ Years of Experience Exclusive Data Mining Services WuXi AppTec has the right experience for the nuanced world of viral clearance and a platform to drive higher LRVs Impeccable Regulatory Track Record WuXi AppTec The Industry Leader Study Designs that Result in Higher LRVs Unmatched Technical Expertise Highly Purified Virus Stocks With industry-leading experience and expertise, we understand the unique challenges that different products may encounter, which may lead to unexpected results. Our team has a proven track record of success especially with products for which it can be a challenge to obtaining high LRVs. For over 25 years, WuXi AppTec has been at the forefront of viral clearance studies no one has more experience or a more highly developed program.
3 study design claim greater log reduction values for your processes YOUR CHALLENGES Designing a robust viral clearances study takes technical horsepower. Inadequate log reduction values can raise regulatory questions. Early-stage studies don t always predict final process results. OUR SOLUTION Using advanced, globally accepted testing approaches, WuXi AppTec s team of experts will design studies that produce better results with higher log-reduction values for your process. Our experienced staff can help design your entire study, assist with the scale-down portions of the project, and then work side-by-side with you during the execution of the study. STUDY EXPERIENCE Products for which we have conducted studies for R&D, Phase 1-3, BLA, Marketing Authorization, and 510K submissions include: Monoclonal antibodies Viral vaccines Recombinant proteins Tissues Blood-derived products Virus removal/inactivation instruments, resins, Gene therapy vectors matrices, and devices PROCESS EXPERIENCE Our experience spans a broad range of different processes, including: INACTIVATION Heat / Pasteurization Low and high ph Solvent / Detergent Irradiation Sterilization High-energy light Ethanol REMOVAL Column chromatography Filtration CLEANING Kinetics of inactivation Coupon studies
4 high titer, highly purified virus stocks The preparation, purification and use of high-titer viral stocks is one of the most critical aspects in the performance and eventual success of a viral clearance study. WuXi AppTec has conducted extensive research to produce highly purified, high-titer virus stocks for use in viral clearance studies. We have set the standard for how these stocks should be made and the results from our clients studies demonstrate the success of our research efforts. Our ultra-purified stocks help ensure the data generated is the most accurate assessment of your processes ability to clear or inactivate virus. They can also dramatically increase total log reduction values (LRV) for nanofiltration and other steps. The LRV results from utilizing these stocks can often provide the necessary clearance to potentially eliminate low LRV steps, greatly reducing the cost of your viral clearance program and process development efforts. Studies have shown that virus purity has the ability to affect process steps as less-purified virus can cause significant interference. Ultrapurified virus stocks can reduce this interference. Industry Standard Virus Purification MVM Capsid photo using Transmission Electron Microscopy (TEM). Note potential cellular debris, cellular membranes and DNA. Ultra 3 Highly Purified Virus Preparation MVM Capsid photo using Transmission Electron Microscopy (TEM). Note high particle count, mono-dispersed, very little cellular debris. Our experience and proprietary process make for the highest purity stocks on the market With our meticulously developed and higly refined approaches to purification techniques, we have three classifications of virus for use in studies: Ultra 1 (standard) Ultra 2 (highly purified Reovirus, PrV and MuLVs) Ultra 3 (highly purified PPV and MVM) Ultra-pure viruses are purified using centrifugation and other proprietary process steps. Our standardized process mitigates the variation of lots and specially developed quality control assays help characterize the purity.
5 data mining services Harnessing the power of a vast database to enable clients informed decision-making WuXi AppTec s Viral Clearance Database is a powerful tool allowing users to query for information related to general or specific process step parameters and how those parameters affect viral clearance/inactivation. With database queries, clients are able to make informed decisions prior to or during critical process changes, which, in turn, permits fine-tuning of the processes helping to avoid costly delays and the inclusion of unnecessary or non-ideal process steps in their viral clearance analysis. For example, a query might review the past results of a specific process step prior to implementing a change or as an alternative to an existing process. Alternatively, the database could be mined to examine the performance and effectiveness of specific conditions that could yield better viral clearance log reduction values. 25+ years of testing results studies 20,000+ data points Supported Products Include: Recombinant proteins Monoclonal antibodies Tissue and plasma products Gene therapy vectors Vaccines Raw materials Devices Database Features: More than 3500 different viral clearance or inactivation studies Information tabulated from 20,000 data points and continuously expanding Log reduction values obtained over a 25-year span Extensive library of inactivation and removal process steps Multiple Search Criteria Include: Process step (AEX chromatography, solvent/detergent, nanofiltration) Virus used (over 30 different types) Process step parameters (ph, flow rate, conductivity) Protein and viral load Infectivity or PCR detection methodology General scale-down parameters for individual processes
6 large-volume testing + virus plaque assay The targeting of robust processes with large volumes of product fractions and filtrates coupled with use of the virus plaque assay has been shown to consistently drive claims of higher log-reduction values for your purification processes. large-volume testing WuXi AppTec has performed many large-volume studies for clients, which have clearly demonstrated that a higher log-reduction value can be realized for a given process step. By testing large volumes of product material in viral clearance studies (e.g., testing a level of filtrate in quantities upwards of >200 ml), your program is best positioned to drive higher log-reduction claims through increasing the sensitivity of the assay so that a greater log reduction can be achieved. virus plaque assay The Virus Plaque Assay is a quantitative virus detection technique preferred for the benefits it yields in driving higher log-reduction values for viral clearance studies. Easily amplified to accommodate large-volume testing, the Virus Plaque Assay has proven to be a more precise method than TCID 50 for detection of infectious units for most viruses, and it facilitates the claim of more log reduction for most processes. spike based on total viral input Historically, all steps for a viral clearance study have been performed on a percent spike basis. WuXi AppTec is defining a new approach to viral clearance study design by transitioning from a percent spike methodology to a total viral load application for all steps. LARGE -VOLUME TESTING Higher Log- Reduction Value + VIRUS PLAQUE + TOTAL VIRAL ASSAY LOAD APPROACH EQUALS More Consistent Data Better Reliability Scientifically sound study designs save time, materials and money by reducing the number of process steps evaluated while maximizing the log reduction values obtained for those steps. You can have confidence in methods that decrease assay variability, ensure reproducibility, and meet global regulatory needs.
7 program highlights Our unmatched experience and expertise, plus exceptional program features can dramatically affect your process development efforts and help ensure your study success. WuXi AppTec is the industry leader in viral clearance studies Impeccable Regulatory Track Record More than 25 Years of Experience Unmatched Technical Expertise Study Designs that Result in Higher LRVs High Titer, Highly Purified Virus Stocks Exclusive Data Mining Services Continuous Processing Option Expanding and Flexible Capacities We have performed more than 3500 viral clearance studies and never had a single study rejected by the global regulatory authorities. Our history of global regulatory perfection is the absolute industry standard. For over 25 years, WuXi AppTec has been at the forefront of performing viral clearance studies for a wide variety of products. No one has more experience or a more highly developed program. WuXi AppTec s experts have the exceptional technical know-how to handle viral clearance studies for even the most difficult molecules, and can assist you in reaching aggressive LRV targets. Based on large-volume testing and the virus plaque assay, our scientifically-sound study designs can help reduce the number of steps needed to clear virus and dramatically increase LRVs. Our ultra-purified stocks help ensure the data generated is the most accurate assessment of your processes ability to clear or inactivate virus, and can also dramatically increase total LRV. Mining our exclusive and vast database derived from 25+ years of testing, studies and 20,000 data points helps clients make informed decisions prior to or during critical process changes. We offer performance of continuous chromatography studies, with flexibility in client equipment selection. Also, we work with clients in R&D settings to build regulatory knowledge and evaluate integrated processes. With our commitment to continual investment to meet client demand, our expansive suite and equipment capacities allow for flexibility, ease of scheduling, quick response and fewer delays.
8 Your Global Streamlined CDMO PLATFORMS + INTEGRATED TESTING Pioneering the accelerated development and commercialization of cell and gene therapies by leveraging platforms and integrated testing advancedtherapies.com CONNECT WITH US WuXiATU
BIOPHARMACEUTICAL PROCESS EVALUATED FOR VIRAL CLEARANCE
The purpose of Viral Clearance evaluation is to assess the capability of a manufacturing production process to inactivate and/or remove potential viral contaminants. Experience and knowledge in selecting
Virus Filtration for Biosimilars : From needs to Solutions
Virus Filtration for Biosimilars : From needs to Solutions 3 rd International Conference and Exhibition on Biowaivers, Biologics and Biosimilars - Hyderabad Tathagata Ray Layout of Presentation 1 Virus
The Eshmuno Chromatography Family of Resins
The Eshmuno Chromatography Family of Resins The perfect accessory for highly productive downstream purification EMD Millipore is a division of Merck KGaA, Damstadt, Germany Introduction For over 300 years,
Modular Retrovirus Clearance in Support of Clinical Development
Modular Retrovirus Clearance in Support of Clinical Development Bio-product Research & Development, Eli Lilly and Company CMC Strategy Forum, Europe, 2018 D. Chen/ M. Murphy General Expectations for Viral
The Future of Viral Validation. Howard L. Levine, Ph.D. Process Validation for Biologicals Carlsbad, CA February 26 27, 2007
The Future of Viral Validation Howard L. Levine, Ph.D. Process Validation for Biologicals Carlsbad, CA February 26 27, 2007 Virus Safety Evaluation and Validation Increased scrutiny and requirements for
Dynamic High Capacity Mustang Q Membrane Units for Scaleable Anion Exchange Chromatography Purification of Adenoviral Vectors
Contact Us: www.pall.com/contact Dynamic High Capacity Mustang Q Membrane Units for Scaleable Anion Exchange Chromatography Purification of Adenoviral Vectors Dynamic High Capacity Mustang Q Membrane Units
The Elite Provider. Cell & Gene. Therapy Manufacturing
The Elite Provider Cell & Gene Therapy Manufacturing GMP Manufacturing Services The cgmp manufacturing in Vigene is compliant with US FDA and EU EMA regulatory requirements. The manufacturing area consists
A Life Cycle Approach to Raw Material Qualification for Cell and Gene Therapy Products
A Life Cycle Approach to Raw Material Qualification for Cell and Gene Therapy Products Angela Whatley, Ph.D. Office of Tissues and Advanced Therapies CBER/FDA CMC Strategy Forum on Cell & Gene Therapies
Subject Index. chromatography step, 125-
A Alert limits, description, 70 Aluminum hydroxide based vaccine manufacture, start up and validation of sterile formulation and filling processes, 144-168 Anion-exchange chromatography step for clinical-grade
Subject Index. See for options on how to legitimately share published articles.
Downloaded via 148.251.232.83 on March 27, 2019 at 03:59:27 (UTC). See https://pubs.acs.org/sharingguidelines for options on how to legitimately share published articles. A Alert limits, description, 70
Viral Clearance Services. Unsurpassed experience, science and compliance
Viral Clearance Services Unsurpassed experience, science and compliance What We Do BioReliance has conducted thousands of Clearance studies for clients around the globe. These studies are required by regulatory
Dinesh Khokal, PhD, Singapore
GaBI Educational Workshops 5 August 2018, Furama Resort Da Nang, Vietnam 1st ASEAN Overview Workshop on GMP for BIOLOGICALS/BIOSIMILARS Dinesh Khokal, PhD, Singapore Director, External Affairs, Corporate
Quality Control Assays
QUALITY CONTROL An integral part of the Penn Vector Core is its robust quality control program which is carried out by a separate quality control group. Quality control assays have been developed and optimized
European Guideline for Virus Safety Evaluation of Clinical Trial Material
Plasma Product Biotechnology Meeting, May 8 12, 2007 European Guideline for Virus Safety Evaluation of Clinical Trial Material Dr. Hannelore Willkommen Vice President Regulatory Affairs, NewLab Bioquality
Outsourcing and Partnering for Commercial Grade Manufacturing Frank Tufaro, Ph.D.
Outsourcing and Partnering for Commercial Grade Manufacturing Frank Tufaro, Ph.D. Should You Partner Manufacturing? $$$ versus Control 2 Ph. 1 Registration Trials Commercial Launch CMO CMO or Partner CMO
Biotechnology: Quality Assurance and Validation
r Biotechnology: Quality Assurance and Validation Drug Manufacturing Technology Series Volume 4 Kenneth E. Avis Carmen M. Wagner Vincent L. Wu Editors Interpharm Press, Inc. Buffalo Grove, Illinois CONTENTS
Virus Safety in Plasma- Derived Therapeutics: A Merck Perspective. IPFA Yogyakarta, March Louis Wong
Virus Safety in Plasma- Derived Therapeutics: A Merck Perspective IPFA Yogyakarta, March 2017 Louis Wong Associate director, Plasma Initiative, Asia-Pacific Content Regulatory Expectations for Plasma-Derived
Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA) PDA, Inc. 2014
Downloaded from journal.pda.org on May 13, 2018 Viral Clearance by Traditional Operations With Significant Knowledge Gaps (Session II): Cation Exchange Chromatography (CEX) and Detergent Inactivation George
MiniTEM. Designed for nanoparticle characterization
MiniTEM Designed for nanoparticle characterization MiniTEM revolutionizes access to transmission Transmission electron microscopy (TEM) is unmatched in providing high resolution images that allow visual
Downscaling Purification Processes for Biologics
Clearance Services Considerations in Downscaling Purification Processes for Biologics O-0280608 About BioReliance BioReliance Corporation is a leading provider of cost-effective contract services to the
Novel Virus Clearance and Virus Detection Technologies and Applications
Novel Virus Clearance and Virus Detection Technologies and Applications Qi Chen, PhD Process Virology, Purification Development Genentech Inc., A Member of the Roche Group CMC Forum Japan December 3, 2018
Vectors for Gene Cloning: Plasmids and Bacteriophages
Vectors for Gene Cloning: Plasmids and Bacteriophages DNA molecule must be able to replicate within the host cell to be able to act as a vector for gene cloning, so that numerous copies of the recombinant
Monoclonal Antibody Purification and Technology for Improving Virus Clearance
Monoclonal Antibody Purification and Technology for Improving Virus Clearance BioProcessing Network Annual Conference Brisbane, September 2009 Germano Coppola Technology Transfer Manager CSL Limited Outline
Process Removal of Impurities in Biotech Products
Process Removal of Impurities in Biotech Products CASSS Midwest Regional Forum October 5, 2017 Warren R. Emery Sr. Research Scientist Bioproduct R&D, Eli Lilly and Company Pharmaceutical Process Development
Overview of Biologics Testing and Evaluation: Regulatory Requirements and Expectations. Audrey Chang, PhD, Senior Director Development Services
Overview of Biologics Testing and Evaluation: Regulatory Requirements and Expectations Audrey Chang, PhD, Senior Director Development Services Definition of Biologics: PHS Act, section 351 Virus, therapeutic
Elwyn Griffiths, DSc, PhD, UK
GaBI Educational Workshops 5 August 2018, Furama Resort Da Nang, Vietnam 1st ASEAN Overview Workshop on GMP for BIOLOGICALS/BIOSIMILARS Elwyn Griffiths, DSc, PhD, UK Former Director General, Biologics
Challenges in Scaling Up Newly Developed Microbial Manufacturing Processes
Challenges in Scaling Up Newly Developed Microbial Manufacturing Processes Susan Dana Jones, Ph.D. BioProcess Technology Consultants BIO Process Zone Theater June 19, 2008 Microbial Process Development
Risk Mitigation in Cell Culture: How to Prevent Viral Contamination
Platzhalter Bild Risk Mitigation in Cell Culture: How to Prevent Viral Contamination Upstream Day New Technology Platforms for Cell & Microbial Cultures May 2013 Claire Roulin, Application Specialist Purification
Adenovirus upstream and downstream processing. Dr. Mats Lundgren GE Healthcare Life Sciences
Adenovirus upstream and downstream processing Dr. Mats Lundgren GE Healthcare Life Sciences Introduction Viral Vectors Number of 2016 active trials clinical phases globally 170 Clinical trials by main
European Medicines Agency
European Medicines Agency October 1997 CPMP/ICH/295/95 ICH Topic Q 5 A (R1) Quality of Biotechnological Products: Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal
Development from Bench to Clinic
Accelerating Novel Vaccine Development from Bench to Clinic Roger Lias. Ph.D. President Eden Biodesign, Inc Questions Questions are encouraged and can be asked by sending an email to: edenbiodesign@propelmg.com
Modular DSP approaches for complex non-mab molecules
Modular DSP approaches for complex non-mab molecules Dr. Stefan R. Schmidt MBA SVP Process Science & Production Agenda 1 Introduction 2 3 4 5 Process related impurities Product related impurities Virus
Filtration of Cell Culture Growth Media and Process Buffers
Customer Application Brief Bioprocess, Biologicals, & Pharmaceutical Filtration of Cell Culture Growth Media and Process Buffers Introduction Media feeds and process buffers are two universal additives
Reference Materials for Adeno-Associated Viruses
Reference Materials for Adeno-Associated Viruses : Recommendations of the Quality Control Sub-Committee John Chiorini (NIH-NIDCR) Paul Husak (Cell Genesys) Gabrielle Kroener-Lux (Progen) James Marich (Cell
A dedicated DSP plant for the production of ClairYg, a LFB liquid Immunoglobulin G preparation for intravenous use
A dedicated DSP plant for the production of ClairYg, a LFB liquid Immunoglobulin G preparation for intravenous use Christophe SEGARD Technical Director Industrial Exploitation LFB 1 1 Objectives of a new
A Regulatory Perspective on Characterization and Control of Process-Related Impurities
A Regulatory Perspective on Characterization and Control of Process-Related Impurities Christopher Downey, PhD FDA/CDER Office of Biotechnology Products CASSS Bay Area Discussion Group June 2017 Disclaimer
Guideline on process validation for the manufacture of biotechnology-derived active substances and data to be provided in the regulatory submission
1 2 3 25 April 2014 EMA/CHMP/BWP/187338/2014 Committee for Medicinal Products for Human Use (CHMP) 4 5 6 7 Guideline on process validation for the manufacture of biotechnology-derived active substances
PATfix TM. Lead the way of your process
PATfix TM Lead the way of your process P A T f i x S O F T W A R E Short description incyght Chromatography Data Science Software Production of high value biological therapeutics usually involves complex
To date, the majority of
B i o P r o c e s s TECHNICAL Evaluating Adsorptive Filtration As a Unit Operation for Virus Removal Mario Metzger, Anja Gerster, Marcus Peiker, Sabine Faust, Alexander Faude, Sybille Ebert, Sophie Winterfeld,
MagSi Beads. Magnetic Silica Beads for Life Science and Biotechnology study
MagSi Beads Magnetic Silica Beads for Life Science and Biotechnology study MagnaMedics Diagnostics B.V. / Rev. 9.2 / 2012 Wide range of products for numerous applications MagnaMedics separation solutions
MAXimum results. Minimum effort.
MAXimum results. Minimum effort. MagMAX sample preparation for veterinary diagnostic testing Sometimes purifying nucleic acid from animal samples can be like trying to pull a needle out of a haystack.
Adenovirus Titration Kit
Adenovirus Titration Kit Catalog # LF-RK0001(1 kit) Immunostaining method for Quantitative Detection of Adenovirus For research use only Not for diagnostic or therapeutic procedures AbFrontier Science
Production and Purification of Virus like particle (VLP) based Vaccine. Priyabrata Pattnaik, PhD Director Worldwide Vaccine Initiative
Production and Purification of Virus like particle (VLP) based Vaccine Priyabrata Pattnaik, PhD Director Worldwide Vaccine Initiative Outline 1 2 3 4 VLPs as Hepatitis C vaccines Baculovirus / insect cell
Improving Bioprocessing Productivity Through the Application of Single-Use Protein A Columns
Improving Bioprocessing Productivity Through the Application of Single-Use Protein A Columns By K. John Morrow, Jr. Ph.D. In the last two decades, the bioprocessing industry has confronted the demands
Manufacturing Viral Gene Therapy Vectors: General Approaches and Challenges John T. Gray
Manufacturing Viral Gene Therapy s: 1 Dr. Vice President, Research & Development Audentes Therapeutics, Inc. San Francisco, USA Natural virus life cycle Late Early Viral Virally infected cell Naïve cell
MAXimum results. Minimum effort.
MAXimum results. Minimum effort. MagMAX sample preparation for veterinary diagnostic testing Sometimes purifying nucleic acid from animal samples can be like trying to pull a needle out of a haystack.
to acquire Investor And Analyst Call Presentation January 4, 2008
to acquire Investor And Analyst Call Presentation January 4, 2008 Safe Harbor Statement The following information contains, or may be deemed to contain, forward looking statements (as defined in the U.S.
NaNoplasmid TM. Platform SIZE MATTERS SMALLER IS BETTER
Nanoplasmid TM Platform NaNoplasmid TM The Nanoplasmid is a dramatically improved Key Cassette (
SPECIALfinder GENERON. Food Allergens Detection Solutions. Food Safety in our Genes
SPECIALfinder Food Allergens Detection Solutions GENERON Food Safety in our Genes Values to rely on GENERON assays feed your safety and quality assurance through our best direct technical support. Generon
Introduction to Protein Purification
Introduction to Protein Purification 1 Day 1) Introduction to Protein Purification. Input for Purification Protocol Development - Guidelines for Protein Purification Day 2) Sample Preparation before Chromatography
VECTOR SAFETY INFORMATION. AAV Vectors: Material Information
VECTOR SAFETY INFORMATION AAV Vectors: Material Information AAV vectors contain recombinant transgene sequences (e.g. encoding reporter or therapeutic genes) flanked by the AAV inverted terminal repeats
Biologics derived from
SUPPLIER Side Advanced Viral Clearance Study Design A Total Viral Challenge Approach to Virus Filtration Michael Burnham, Alexander Schwartz, Esha Vyas, Nanna Takahashi, Pauline Nemitz, Daniel Strauss,
Process-Scale Chromatography Your Key to a Successful Journey
Process-Scale Chromatography Your Key to a Successful Journey EMD Millipore is a division of Merck KGaA, Darmstadt, Germany Chromatography: Your Key to a Successful Journey The journey of a drug to market
Simplicity is the key Continuous purification of monoclonal antibodies
Simplicity is the key Continuous purification of monoclonal antibodies L. Landric-Burtin Head of Downstream Processing Development, France Integrated Continuous Biomanufacturing Conference, Barcelona,
5 min dsrna Extraction Kit
5 min dsrna Extraction Kit Most plant viruses have RNA genomes that can be single stranded or double stranded. During replication of viruses in plant, high molecular weight double-stranded ribonucleic
Viral vectors Overcoming process. Dave Simpson PhD Process Development Manager
Viral vectors Overcoming process challenges to meet the clinical demands Dave Simpson PhD Process Development Manager Eden Biodesign Ltd Questions Questions are encouraged throughout the presentation and
POROS HQ 50 and PI 50 resins in flow-through polish chromatography applications
APPLICATION NOTE POROS HQ 50 and PI 50 Resins POROS HQ 50 and PI 50 resins in flow-through polish chromatography applications Why and where to start? Introduction Anion exchange (AEX) chromatography products
A novel approach to Protein A capture chromatography to help decrease cost of clinical manufacturing and reduce supply chain risk
PRODUCT BULLETIN POROS MabCapture A resins A novel approach to Protein A capture chromatography to help decrease cost of clinical manufacturing and reduce supply chain risk Introduction As cell culture
Rachel Legmann, PhD ISCT, October 2, 2016 Memphis, TN
Industrialization of adenoviral vector production in an icellis 500 fixed bed bioreactor for the creation of autologous insulin producing liver cells for the treatment of diabetes: From bench to clinical
ICH Considerations. Oncolytic Viruses September 17, 2009
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH Considerations Oncolytic Viruses September 17, 2009 1. Introduction Oncolytic viruses
Critical Quality Attributes for Live Viral Vaccines. Mark S. Galinski Vaccine Analytical Sciences, MedImmune, Mountain View, CA USA
Critical Quality Attributes for Live Viral Vaccines Mark S. Galinski Vaccine Analytical Sciences, MedImmune, Mountain View, CA USA Terminology Quality Release Standards The specifications and procedures
Welcome Biotech 101. Outline. Before the Floor. Manufacturing Process. Supporting Cast 4/22/2013
Welcome Biotech 101 Outline Before the Floor All the activities that happen before large scale cgmp manufacturing Manufacturing Process Manufacturing steps Equipment Requirements How it all works together
Amplification of Cre- expressing Adenovirus in 293T cells Jointly prepared by Lauren, Kazu, and Bingnan July 2011
Amplification of Cre- expressing Adenovirus in 9T cells Jointly prepared by Lauren, Kazu, and Bingnan July Background on AdenoCre IRE EGFP system (Vector Biolabs, Ad- Cre- IRE- GFP, cat# 7), titer is x
Phenyl Membrane Adsorber for Bioprocessing
Phenyl Membrane Adsorber for Bioprocessing Sartobind Hydrophobic Interaction Membrane Chromatography The low substitution of the phenyl ligand on the membrane allows for mild elution of biomolecules such
TOYOPEARL GigaCap Series
TOYOPEARL GigaCap Series INTRODUCTION Ion Exchange Chromatography (IEC) is one of the most frequently used chromatographic modes for the separation and purification of biomolecules. Compared with other
Biologics. Biologics. The Centre for Process Innovation. From innovation to commercialisation
Biologics Biologics The Centre for Process Innovation From innovation to commercialisation The Centre for Process Innovation From innovation to commercialisation The High Value Manufacturing Catapult is
Downsizing downstream processing: A novel single-use purification platform for biologics
Downsizing downstream processing: A novel single-use purification platform for biologics James Stout, PhD VP, Process Sciences BPI Boston, October 2015 Natrix Separations Inc. Burlington, Ontario, Canada
The Molecular Virology Support Core: Adenoviral Vectors and Beyond
The : Adenoviral Vectors and Beyond Christoph A. Kahl, Ph.D. Viral Vector Workshop, May 5th, 2011 Outline 1) Overview of the MVSC 2) Adenoviral Vectors 3) Expertise and Services Overview What does the
Virus- infectious particle consisting of nucleic acid packaged in a protein coat.
Chapter 19 Virus- infectious particle consisting of nucleic acid packaged in a protein coat. Most scientists consider viruses non-living because they cannot reproduce or carry out metabolic activities
cgmp Cell & Gene Therapy
Updated Edition cgmp Cell & Gene Therapy AAV, Adenovirus, and Lentivirus PD and Production Handbook Vigene - the cgmp Viral Vector Experts Table of Contents Vigene cgmp overview... 3 Vigene manufacturing
Simplifying ImmunoAffinity Capture Workflow
CAE TUDY MART Digest ImmunoAffinity (IA) Kit implifying ImmunoAffinity Capture Workflow Rapid, ensitive, LC-RM Quantitative Analysis of Proteins in Plasma As pharmaceuticals grow more efficacious, reporting
CHAPTER 24. Immunology
CHAPTER 24 Diagnostic i Microbiology and Immunology Growth-Dependent Diagnostic Methods Isolation of Pathogens from Clinical Specimens Proper sampling and culture of a suspected pathogen is the most reliable
Schedule for BioSc147: Molecular and Cellular Biology: Topics, Discussions, Readings, Labs, Due dates
Schedule for BioSc147: Molecular and Cellular Biology: Topics, Discussions, Readings, Labs, Due dates Week Date Topics Article Chapter Lab Due.pdf of lecture slides arranged by topic on course web page.
New proposal from the EC:
New proposal from the EC: Gene therapy medicinal product means a biological medicinal product which has the following characteristics: a. it contains an active substance which contains or consists of a
Affinity Chromatography Media. Cellufine Sulfate. Technical Data Sheet
Affinity Chromatography Media Cellufine Sulfate Technical Data Sheet Cellufine Sulfate For concentration, purification and depyrogenation of virus, viral/microbial antigens and heparin-binding proteins
Synthetic vaccine research and development. Comprehensive and innovative synthetic biology solutions and technologies
Synthetic vaccine research and development Comprehensive and innovative synthetic biology solutions and technologies From plan to product, Thermo Fisher Scientific supports your synthetic vaccine goals
Adsorptive and Mechanical Mechanisms of Fluid Purification Using Charge Modified Depth Filtration Media. Dr. Robert Conway, Ph.D.
Adsorptive and Mechanical Mechanisms of Fluid Purification Using Charge Modified Depth Filtration Media Dr. Robert Conway, Ph.D. Depth Filter Cartridge Construction Zeta Plus Media Materials of Construction
Phenyl Membrane Adsorber for Bioprocessing
Phenyl Membrane Adsorber for Bioprocessing Sartobind Hydrophobic Interaction Membrane Chromatography The low substitution of the phenyl ligand on the membrane allows for mild elution of biomolecules such
Applied Biosystem Prism 6700 Automated Nucleic Acid Workstation
www.ietltd.com Proudly serving laboratories worldwide since 1979 CALL 001.847.913.0777 for Refurbished & Certified Lab Equipment Applied Biosystem Prism 6700 Automated Nucleic Acid Workstation The ABI
High Pure RNA Isolation Kit for isolation of total RNA from 50 samples Cat. No
for isolation of total RNA from 50 samples Cat. No. 1 88 665 Principle A single reagent lyses the sample lysis and inactivates RNase. In the presence of a chaotropic salt (guanidine HCl), the released
Chapter 13A: Viral Basics
Chapter 13A: Viral Basics 1. Viral Structure 2. The Viral Life Cycle 3. Bacteriophages 1. Viral Structure What exactly is a Virus? Viruses are extremely small entities that are obligate intracellular parasites
Isolation of Viral RNA, Viral DNA and Bacterial DNA from Animal Samples
Application Note Isolation of Viral RNA, Viral DNA and Bacterial DNA from Animal Samples Denis Flüge, Lillian Krüger, Sandy Leifholz and Holger Engel R&D Department, QIAGEN GmbH, QIAGEN Straße 1, Hilden,
PAXgene Blood DNA PAXgene Blood DNA Tube (IVD) for clinical use PAXgene Blood DNA System (RUO) for research use. Explore more at
PAXgene Blood DNA PAXgene Blood DNA Tube (IVD) for clinical use PAXgene Blood DNA System (RUO) for research use Explore more at www.preanalytix.com Situation The composition, amount, quality and integrity
Retrovirus Purification Miniprep Manual
Retrovirus Purification Miniprep Manual Catalog# RV01-01, RV01-02 For research use only (October 2012) Table of Contents Introduction... 4 Storage and Stability... 4 Before Starting... 4 Kit Contents...
Outline. Upstream Processing: Development & Optimization
Upstream Processing: Development & Optimization Kamal Rashid, Ph.D., Director Biomanufacturing Education & Training Center Worcester Polytechnic Institute Outline Introduction to Upstream processing Microbial
Japanese Application Form: PMDA s Perspective on Manufacturing Process Description
Japanese Application Form: PMDA s Perspective on Manufacturing Process Description Reiko YANAGIHARA, Ph.D. Principal Reviewer Division of Pharmacopoeia and Standards for Drugs Office of Standards and Guideline
ViraBind PLUS Retrovirus Concentration and Purification Mega Kit
Product Manual ViraBind PLUS Retrovirus Concentration and Purification Mega Kit Catalog Number VPK-136 VPK-136-5 2 preps 10 preps FOR RESEARCH USE ONLY Not for use in diagnostic procedures Introduction
Human Protein Process Sciences, Lille, France 2. Shabrawishi Hospital Blood Bank, Cairo, Egypt 3. University of Saskatoon, Canada
1 Human Protein Process Sciences, Lille, France 2 Shabrawishi Hospital Blood Bank, Cairo, Egypt 3 University of Saskatoon, Canada Why such a concept? Non-virally inactivated plasma components are still
ExoQuick ULTRA EV Isolation Kit for Serum and Plasma
ExoQuick ULTRA EV Isolation Kit for Serum and Plasma Cat # EQULTRA-20A-1 User Manual Storage: Please see individual components Version 2 6/29/2018 A limited-use label license covers this product. By use
Adenoviral Expression Systems. Lentivirus is not the only choice for gene delivery. Adeno-X
Adenoviral Expression Systems Lentivirus is not the only choice for gene delivery 3 Adeno-X Why choose adenoviral gene delivery? Table I: Adenoviral vs. Lentiviral Gene Delivery Lentivirus Adenovirus Infects
E.Z.N.A. HP Viral RNA/DNA Kit. R preps R preps
E.Z.N.A. HP Viral RNA/DNA Kit R6873-00 5 preps R6873-01 50 preps August 2013 E.Z.N.A. HP Viral RNA/DNA Kit Table of Contents Introduction and Overview...2 Kit Contents/Storage and Stability...3 Preparing
Raw Materials: Sourcing and Qualification Testing
Raw Materials: Sourcing and Qualification Testing Scott R. Burger, MD Advanced Cell & Gene Therapy Technical Applications Track 2 ISCT 2009 Sourcing Raw Materials Raw materials for cell/gene therapy manufacturing
ViraBind PLUS Retrovirus Concentration and Purification Kit
Product Manual ViraBind PLUS Retrovirus Concentration and Purification Kit Catalog Number VPK-135 2 preps FOR RESEARCH USE ONLY Not for use in diagnostic procedures Introduction Retroviral gene transfer
ViraBind Lentivirus Concentration and Purification Kit
Product Manual ViraBind Lentivirus Concentration and Purification Kit Catalog Number VPK-091 VPK-091-5 5 preps 25 preps FOR RESEARCH USE ONLY Not for use in diagnostic procedures Introduction Lentivirus
Capto adhere ImpRes. GE Healthcare Life Sciences. Polishing medium for MAb platform processes
GE Healthcare Life Sciences Data file 29-344-97 AA Multimodal chromatography Capto adhere ImpRes Capto adhere ImpRes is a BioProcess chromatography medium (resin) for high-resolution polishing of monoclonal
ViraBind Lentivirus Concentration and Purification Kit
Product Manual ViraBind Lentivirus Concentration and Purification Kit Catalog Number VPK-090 2 preps FOR RESEARCH USE ONLY Not for use in diagnostic procedures Introduction Lentivirus vectors based on
EasyPrep TM Adeno-associated Virus Purification Mini Kit Manual
EasyPrep TM Adeno-associated Virus Purification Mini Kit Manual Catalog#: AAV01-00, AAV01-01, AAV01-02 For research use only (October 2013) Table of Contents Introduction... 4 Storage and Stability...
Monoclonal antibodies (mabs)
Validating Virus Clearance in a Single-Use System Part 1: Film Adsorption and Virus Inactivation Studies RONAN MCCARTHY, NICK HUTCHINSON, ISABELLE UETTWILLER, AMÉLIE BOULAIS, FRANÇOIS COUTARD, EVE DEPAW,
Basic concept of chromatography
Biotechnology & Genetic Engineering Lecture (5) Assi. Prof. Rajaa Al Anbaqi Basic concept of chromatography = a group of separation techniques, which are characterized by az distribution of the molecules
Strategic Considerations for Manufacturing Process Development
Strategic Considerations for Manufacturing Process Development PDA Israel Key areas for strategic drug development planning Ramat Gan, 24th Oct 2018 Oren Hesrhkovitz GM, Opko Biologics Presentation Overview